More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...

Over the last 5 years, the share price of NTC Industries has gained 16.11% CAGR. Over the past year, the corresponding return has been -5.73%. NTC Industries’s current P/E of 12.21x helps give context ...

In a potentially pivotal trial, PTC Therapeutics' experimental therapy for Huntington's disease (HD) met its primary endpoint, but questions about the data have raised doubts about the company's ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

PTC India Limited (PTC) is a provider of power trading solutions in India. The Company is engaged in investing in equity or extending debt to power projects in generation, transmission, distribution, ...

PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

PTC Inc insiders executed 25 transactions on February 11, 2026, with a total reported value of $38,664.27. Most activity involved routine conversions and awards, with only 2 sales totaling $38,664.27.